Drug retention rate of Janus kinase inhibitors in patients with rheumatoid arthritis: the KEIO-RA cohort study

Drug retention rate of Janus kinase inhibitors in patients with rheumatoid arthritis: the KEIO-RA cohort study

<p>This study aimed to investigate the effectiveness and safety of Janus kinase inhibitors (JAKis) in patients with rheumatoid arthritis (RA) in the real world. All consecutive patients with RA from the KEIO-RA cohort who had received a JAKi from July 2013 to June 2023 were included. We assess...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsman: Satoshi Takanashi (15221350) (author)
Övriga upphovsmän: Masatoshi Kawai (2074750) (author), Mitsuhiro Akiyama (3412106) (author), Yasushi Kondo (371654) (author), Shuntaro Saito (4519816) (author), Masaru Takeshita (6197132) (author), Jun Kikuchi (266172) (author), Hironari Hanaoka (3910738) (author), Yuko Kaneko (839653) (author)
Publicerad: 2025
Ämnen:
Biochemistry
Medicine
Pharmacology
Biotechnology
Ecology
Immunology
Developmental Biology
Science Policy
Chemical Sciences not elsewhere classified
Rheumatoid arthritis
JAK inhibitors
difficult-to-treat rheumatoid arthritis
retention rates
effectiveness
safety
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk